The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study

Autor: Mitelpunkt, Alexis, Kramer, Uri, Hausman Kedem, Moran, Zilbershot Fink, Efrat, Orbach, Rotem, Chernuha, Veronika, Fattal-Valevski, Aviva, Deutsch, Lisa, Heffetz, Daphna, Sacks, Hagit
Zdroj: In Epilepsy & Behavior September 2019 98 Part A:233-237
Databáze: ScienceDirect